Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 8,648 $ 14,042
Accounts receivable 52 59
Inventory, current 464 488
Prepaid expenses and other current assets 1,093 781
Total current assets 10,257 15,370
Fixed assets, net 1,237 1,325
Inventory, non-current 334 511
Right-of-use assets 390 428
Other non-current assets 13 13
Total assets 12,231 17,647
Current liabilities:    
Current portion of long-term debt, net of unamortized debt discount of $168 and $182, respectively 2,611 2,532
Accounts payable and accrued expenses 1,472 1,969
Operating lease liabilities - current 248 245
Other current liabilities 47 53
Total current liabilities 4,378 4,799
Convertible note, net of unamortized debt discount of $94 and $108, respectively 3,906 3,892
Long-term debt, net of unamortized debt discount of $104 and $135, respectively 3,904 4,589
Contingent royalty obligation 992 1,212
Operating lease liabilities - non-current 136 178
Total liabilities 13,316 14,670
Commitments and contingent liabilities (Note 9)
Shareholders’ (deficiency) equity    
Common stock $0.0001 par value;115,000,000 shares authorized; 4,778,873 and 4,659,769 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively
Additional paid-in capital 144,652 144,328
Accumulated deficit (145,737) (141,351)
Total shareholders’ (deficiency) equity (1,085) 2,977
Total liabilities and shareholders’ (deficiency) equity $ 12,231 $ 17,647